Identification of area-level influences on regions of high cancer incidence in Queensland, Australia: a classification tree approach by Cramb, Susanna M et al.
RESEARCH ARTICLE Open Access
Identification of area-level influences on regions
of high cancer incidence in Queensland, Australia:
a classification tree approach
Susanna M Cramb
1,2*, Kerrie L Mengersen
2 and Peter D Baade
1,3
Abstract
Background: Strategies for cancer reduction and management are targeted at both individual and area levels.
Area-level strategies require careful understanding of geographic differences in cancer incidence, in particular the
association with factors such as socioeconomic status, ethnicity and accessibility. This study aimed to identify the
complex interplay of area-level factors associated with high area-specific incidence of Australian priority cancers
using a classification and regression tree (CART) approach.
Methods: Area-specific smoothed standardised incidence ratios were estimated for priority-area cancers across 478
statistical local areas in Queensland, Australia (1998-2007, n = 186,075). For those cancers with significant spatial
variation, CART models were used to identify whether area-level accessibility, socioeconomic status and ethnicity
were associated with high area-specific incidence.
Results: The accessibility of a person’s residence had the most consistent association with the risk of cancer
diagnosis across the specific cancers. Many cancers were likely to have high incidence in more urban areas,
although male lung cancer and cervical cancer tended to have high incidence in more remote areas. The impact
of socioeconomic status and ethnicity on these associations differed by type of cancer.
Conclusions: These results highlight the complex interactions between accessibility, socioeconomic status and
ethnicity in determining cancer incidence risk.
Keywords: cancer incidence, socioeconomic factors, indigenous population, rural health, classification and regression
tree
Background
Globally, almost 12.7 million people were diagnosed with
cancer in 2008 (excluding non-melanoma skin cancers),
and 7.6 million people died from cancer [1]. Cancer was
the third highest cause of death (following cardiovascular
disease and infectious and parasitic diseases) [2].
In Australia, cancer was responsible for almost 40,000
deaths and 108,368 diagnoses (again, excluding non-mela-
noma skin cancer) in 2007 [3]. Cancer was estimated to be
the greatest contributor to the burden of disease, causing
19% of the entire disease burden, and half of this was due
to lung, colorectal, prostate and breast cancers [3]. Due to
its high morbidity and mortality, cancer is an Australian
government health priority area, with specific emphasis
placed on the National Health Priority Area (NHPA) can-
cers of colorectal cancer, lung cancer, melanoma, non-
melanoma skin cancer, breast cancer, cervical cancer,
prostate cancer and non-Hodgkin’s lymphoma [4].
Government strategies for cancer reduction and man-
agement are targeted at both the individual and area
levels. Recognised risk factors at the individual level for
cancer incidence include tobacco smoke exposure, ultra-
violet exposure, diet, exercise and genetics [5]. Evidence
is accumulating that area-level effects, such as socioeco-
nomic inequality, ethnic composition, civic engagement,
government policies and accessibility can shape many of
the individual risk factors [6]. Area-level strategies
require careful understanding of geographic differences
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factors such as socioeconomic status, ethnicity and acces-
sibility. These factors are not independent, since rural
and remote regions of Australia are more likely to be of
lower socio-economic status, and similarly urban areas
are more likely to have higher socio-economic status [7].
This study aimed to identify the complex interplay of
area-level factors associated with areas of high incidence
of the Australian priority cancers, and through this
demonstrate the application of classification and regres-
sion trees (CART) for this purpose. Unlike more tradi-
tional regression models, CART models are able to
identify interactions between ecological factors that best
split geographical areas into homogenous subgroups based
on their relative incidence rates.
Methods
Incidence data for the NHPA cancers (excluding non-mel-
anoma skin cancer) covering the period 1998-2007 were
obtained from the Queensland Cancer Registry (QCR)
after obtaining approval from Queensland Health (Ethics
approval number: HREC/09/QHC/25). The QCR is a
population-based registry, which maintains a record of all
cancer cases (excluding non-melanoma skin cancer) diag-
nosed in Queensland since 1982, and to which notification
is required by law [8]. Cancers were classified according to
the World Health Organization’s International Classifica-
tion of Diseases for Oncology, 3
rd edition (ICD-O3). Popu-
lation estimates were obtained from the Australian Bureau
of Statistics (ABS) [9,10].
The geographic regions used for this analysis are Statisti-
cal Local Areas (SLAs) which cover Queensland without
gap or overlap. In 2006 there were 478 SLAs, ranging in
population size from 7 to 77,523, with a median popula-
tion of 5,810. SLAs were categorised by accessibility,
socio-economic status and Indigenous composition.
Accessibility was defined by the Accessibility/Remoteness
Index of Australia (ARIA+), which categorises areas as
‘Major Cities (MC)’, ‘Inner Regional (IR)’, ‘Outer Regional
(OR)’, ‘Remote (R)’ or ‘Very Remote (VR)’ [11]. These
categories are determined by the minimum road distance
from population localities to different levels of service cen-
tres [11]. Socioeconomic status was defined using the
Socioeconomic Indexes for Areas (SEIFA) Index of Rela-
tive Socioeconomic Disadvantage (IRSD) [12]. SLAs in
Queensland were ranked from the most disadvantaged to
the least disadvantaged and then divided into quintiles.
For clarity we refer to the quintiles as ‘Most Disadvantaged
(MD)’, ‘Moderately Disadvantaged (ModD)’, ‘Middle SES
(MSES)’, ‘Moderately Advantaged (ModA)’ and ‘Most
Advantaged (MA)’. For ease of reference, ‘advantaged’
areas include ‘most advantaged’ and ‘moderately advan-
taged’,a n ds i m i l a r l yf o r‘disadvantaged’ areas. SLAs were
considered to be Indigenous if at least 10% of the
population identified as Aboriginal or Torres Strait Islan-
der in the 2006 population census [13].
The data analysis comprised four main steps: (i) estimat-
ing smoothed Standardised Incidence Ratios (SIRs) for
each cancer; (ii) identifying cancers with significant spatial
variation; (iii) identifying SLAs with “high” incidence for
each cancer, based on the smoothed SIR estimates, and
(iv) for these cancers, identifying the area-level factors
associated with high incidence SLAs.
For Step (i), incidence data were adjusted for age by
indirect standardization to provide empirical SIRs by can-
cer type and gender. A Bayesian hierarchical spatial
smoothing model (known as the Besag, York and Mollié
model) was then applied to produce smoothed SIRs [14].
This model assumes that neighbouring SLAs should be
more similar than SLAs further away, with respect to the
SIR values (or the associated factors, such as accessibility,
socio-economic status and ethnicity). Thus smoothed SIR
estimates are to some extent averaged over neighbouring
values; this also helps address the problem of unstable
empirical estimates that are based on small population
sizes [15]. The model was run using Stata interfaced with
WinBUGS [16]. Further details regarding the methodology
are described elsewhere [17].
We restricted the detailed analyses to those cancers that
had significant sex-specific area-level variation, or hetero-
geneity, in the smoothed SIR estimates (Step (ii)). This
area-level variation was assessed using the Tango’s Maxi-
mised Excess Events Test (MEET) [18]. Values of Tango’s
MEET that were < 0.05 were deemed to reflect statistically
significant variation in estimates.
For Step (iii), the smoothed SIR estimates were classi-
fied as ‘high’ if they were at least 10% greater than the
Queensland average. Sensitivity analyses examining the
influence of alternate cutpoints (5% and 15% above the
Queensland average) were also conducted.
For Step (iv), a weighted CART model was fitted for
each of the cancers selected in Step (ii). The aim of the
CART model is to identify a sequence of binary splits of
the area-level factors (accessibility, socioeconomic status,
ethnicity) that best divide the high/not high smoothed
SIRs for each SLA into homogeneous subgroups. The
resultant sequence of splits resembles a tree-like structure,
and the final subgroups are known as ‘terminal nodes’ that
can be described as high if the estimated Pr(high SIR) is
greater than 0.5. The best tree was chosen using the mini-
mum cross-validation criterion, which chooses the tree
with the lowest expected error if new data were to be
applied to this model (cross-validated error) [19]. In all
cases this gave the same result as using the alternative
one-standard-error rule, which is calculated as the tree
with the fewest nodes which has a cross-validated error
below the sum of the minimum cross-validated error and
its standard error [19]. The CART analysis was conducted
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tated code is provided in the Appendix. To adjust for dif-
ferences in the precision of the smoothed SLA-specific
estimates, the inverse of the variance was used to weight
the dichotomous SIR variable.
The sensitivity and specificity for each final tree was
also calculated. Sensitivity was the weighted sum of true
positive values divided by the weighted sum of false
negative values. Similarly, specificity was calculated as
the weighted sum of false positive values divided by the
weighted sum of true negative values.
In the CART diagrams, the terminal nodes are por-
trayed by rectangles. Within each terminal node (or rec-
tangle) are three rows of numbers. The first contains the
number of SLAs with a high SIR value versus the total
number of SLAs in the node. The second row contains
the Pr(H) value, which is the weighted proportion of
SLAs with a high SIR in the subgroup of SLAs repre-
sented in the node. The third row contains the 95% con-
f i d e n c ei n t e r v a l( C I )f o rt h ep r o b a b i l i t yo fah i g hS I R ,
calculated as p ± 1.96 ×

p(1 − p)
n
where p is the Pr(H)
and n is the number of SLAs. In the few instances where
a CI value surpassed the possible (0,1) boundaries, this
was restricted to the appropriate boundary value. The
CART diagrams are also accompanied by summary dia-
grams showing which areas were likely to have high SIR
values (shaded as dark grey), and which were likely to not
have high SIR values (shaded as light grey). These contain
ARIA and SEIFA combinations to facilitate comparison
between cancer types. Combinations which do not exist
were rendered in white. Note the same shading is also
used for the terminal nodes in the CART diagram. Dark
grey terminal nodes are likely to have a high SIR, in con-
trast to the light grey terminal nodes.
Results
The cancers that had statistically significant evidence of
variation in the smoothed SIR estimates were lung can-
cer, melanoma, breast cancer (females), cervical cancer,
prostate cancer, and non-Hodgkin lymphoma (Table 1).
There was no significant evidence of geographical varia-
tion in colorectal cancer incidence for males (p = 0.693)
or females (p = 0.216). The sensitivity of the final CART
models ranged from 51.5% (female lung cancer) to
97.2% (female non-Hodgkin lymphoma), while the speci-
ficity ranged from 31.1% (female melanoma) to 82.7%
(female lung cancer) (Table 1).
Lung cancer
For lung cancer among males, socioeconomic status
was the primary determinant, whereas for females it was
the accessibility of an area (Figure 1). There were
interactions between socioeconomic status and accessi-
bility for both genders. Areas were more likely to have
increased lung cancer incidence among males if they
were disadvantaged or were remote and very remote
areas of middle SES. Areas within major cities of middle
or disadvantaged SES were likely to have a high inci-
dence of lung cancer among females.
Melanoma
Contrasting patterns were observed for melanoma inci-
dence among males and females. Among males, an area
was likely to have a high melanoma incidence if it was
classified as a major city, inner or outer regional area
and of middle or advantaged SES (Figure 2). In contrast,
for females, incidence was higher in all areas except
those within the most advantaged quintile, and the very
remote areas. Therefore areas of disadvantage were
likely to have high incidence among females, but low
incidence among males.
Female breast cancer
Breast cancer incidence was likely to be high in areas
within major cities, except those that were most disad-
vantaged. Inner regional areas that were most advan-
taged were also likely to have high incidence (Figure 3).
Cervical cancer
Areas that had the highest probability of having
increased cervical cancer incidence were those that were
most disadvantaged or were in outer regional, remote or
very remote areas (Figure 4). However there was also
interaction in areas with high Indigenous population;
areas that were most disadvantaged, were in outer regio-
nal or remote areas and also had a low Indigenous
population were more likely to not have a high cervical
cancer incidence. Corresponding areas with a high Indi-
genous population were likely to have a high cervical
cancer incidence.
Prostate cancer
Inner and outer regional areas, as well as the socioeco-
nomically most advantaged areas within major cities
were likely to have high incidence of prostate cancer
among males (Figure 5).
Non-Hodgkin’s lymphoma
High incidence of non-Hodgkin’s lymphoma was likely
to occur among males in major cities or inner regional
areas, and among females in major cities (Figure 6).
Discussion
The accessibility of a person’s residence was the greatest
predictor of an increased risk of cancer diagnosis across
a range of cancers, including lung (females), melanoma,
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lymphoma. Socioeconomic status was the greatest pri-
mary explanatory variable for lung cancer (males).
More remote areas had a greater probability of having
high incidence of lung cancer among males, and cervical
cancer. Cancers for which more urban areas were more
likely to have high incidence included: lung cancer
(females), melanoma, breast cancer, prostate cancer, and
non-Hodgkin’s lymphoma.
The interaction between accessibility, socioeconomic
status and ethnicity varied depending on the type of can-
cer. The socioeconomic status interacted with accessibil-
ity for lung, melanoma, breast (females), cervical, and
prostate cancers. The incidence of cancers that were
often screen detected such as breast cancer (females),
melanoma (males) and to a lesser extent prostate cancer
tended to be higher in more affluent areas, and also more
urban areas. In contrast, for lung, melanoma (females)
and cervical cancer the incidence was higher in more dis-
advantaged areas. Cancers with a high incidence in disad-
vantaged areas did not have a consistent interaction with
accessibility. Some tended to be higher in more urban
areas (such as lung cancer (females) and melanoma
(females)), while others were higher in more remote
areas (lung cancer (males) and cervical cancer). Ethnicity
also interacted with these factors for cervical cancer, with
Indigenous areas more likely to have high incidence.
These results are consistent with previous studies
showing an increased incidence of cervical cancers
among Indigenous women [21], and an increased inci-
dence of breast cancer among women in more urban or
affluent areas [22]. However, there are also important dif-
ferences compared to previous research. Melanoma inci-
d e n c eh a sg e n e r a l l yb e e nf o u n dt ob eh i g h e ri nm o r e
affluent areas [23]. In contrast, our results found females
in the most advantaged areas were less likely to have high
incidence, while all other SLAs (except for very remote)
were more likely to have high incidence. Queensland has
among the highest rates of melanoma in the world [3,24],
and this may be impacting on these differences. Similarly,
lung cancer incidence has previously been shown to be
higher in remote areas for both males and females [25].
However, our results found high incidence among
females in the lower socioeconomic areas of major cities.
Individual risk factors could be influencing these geo-
graphic differentials. Lung cancer incidence is strongly
determined by smoking prevalence 20-30 years earlier
[26]. Tobacco smoking has been shown to be more pre-
valent in lower SES or more remote areas, which may
explain the high incidence observed in these areas
[27-32]. Similarly, women in affluent areas are more
likely to delay childbearing, have fewer children and/or
use hormone replacement therapy, all of which are risk
factors for breast cancer [33-35].
Preventive measures can also differ geographically. The
leading cause of cervical cancer is infection with sexually
transmitted human papillomaviruses. Papanicolaou
screening (commonly called pap smear testing) detects
precancerous lesions, which can then be treated, averting
cancer and thus lowering incidence. The high incidence
observed in very remote, Indigenous or the most disad-
vantaged urban areas may result from lower uptake of
pap smears. Participation rates for cervical cancer screen-
ing (papanicolaou screening) are lower in remote com-
munities and areas of low socioeconomic status in
Queensland and throughout Australia [36,37].
In contrast, screening for asymptomatic cancers, such
as prostate or breast cancer, can be associated with
Table 1 Summary of area-level variation for National Health Priority Area cancers and CART analysis results
Type of cancer (ICD-O3
code)
Gender Tango’s
MEET
Number of SLAs with high SIR
(%)
Sensitivity Specificity Variables in final
tree
1,2
Colorectal cancer M 0.693 NA NA NA NA
(C18-C20, C218) F 0.216 NA NA NA NA
Lung (C33-C34) M 0.001 153 (32%) 70.1% 74.9% SEIFA, ARIA
F 0.001 83 (17%) 51.5% 82.7% ARIA, SEIFA
Melanoma M 0.001 91 (19%) 75.0% 49.8% ARIA
(C44 and M872-M879) F 0.004 54 (11%) 93.7% 31.1% ARIA, SEIFA
Breast (C50) F 0.001 79 (17%) 86.5% 58.1% ARIA, SEIFA
Cervical (C53) F 0.023 81 (17%) 79.2% 79.3% ARIA, I, SEIFA
Prostate (C61) M 0.001 93 (19%) 70.1% 58.5% ARIA, SEIFA
Non-Hodgkin’s lymphoma M 0.001 57 (12%) 90.1% 38.7% ARIA
(M959,M967-M971) F 0.002 57 (12%) 97.2% 55.2% ARIA
1. The final tree based on the lowest cross-validated error.
2. NA: since there was no evidence of area-level variation for colorectal cancer, additional analysis was not conducted for colorectal cancer.
ARIA: Accessibility/Remoteness index of Australia
I: Indigenous
SEIFA: Socioeconomic indexes for areas
Cramb et al. BMC Cancer 2011, 11:311
http://www.biomedcentral.com/1471-2407/11/311
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diagnostic services is another factor which influences
incidence and can vary by area. For instance, the inci-
dence of prostate cancer may be inflated in areas where
prostate-specific antigen (PSA) testing, which is used to
detect asymptomatic prostate cancer, is commonly used.
PSA testing is less common in more rural areas than in
capital cities throughout Australia [38], and this could
be contributing to the lower incidence in remote areas.
Breast cancer may also be influenced by geographic
Middle SES or Advantaged  Disadvantaged 
Advantaged  Middle SES 
Major City 
Inner Regional to 
Very Remote 
Inner or Outer 
Regional 
Remote or Very 
Remote 
4/8 
Pr(H)=0.65 
(0.32,0.98) 
108/192 
Pr(H)=0.74 
(0.68,0.80) 
19/190 
Pr(H)=0.18 
(0.12,0.23) 
13/53 
Pr(H)=0.41 
(0.28,0.54) 
7/35 
Pr(H)=0.48 
(0.32,0.65) 
Males 
Inner Regional 
to Very Remote 
Major City 
Advantaged  Middle SES and
Disadvantaged 
31/226 
Pr(H)=0.37 
(0.30,0.43) 
18/153 
Pr(H)=0.40 
(0.32,0.48) 
34/99 
Pr(H)=0.74 
(0.65,0.83) 
Females 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
Figure 1 The final classification and regression tree for lung cancer.
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Page 5 of 11variation in screening services, as there is variation in
mammogram uptake by accessibility and socioeconomic
status [39]. Similarly, the ease of access to skin cancer
checking services in more urban areas may influence the
incidence of melanoma.
Strengths of the study include the use of routinely col-
lected incidence data from a population-based registry
to which notification of cancer is required by law.
Queensland has the most decentralized population in
Australia [40], thus providing a unique opportunity to
investigate these area-based differences in greater detail.
Limitations of the study include the nature of cancer,
which takes years to develop and be diagnosed. There-
fore it is possible that the incidence of an area may
reflect the risk factor prevalence from years earlier,
rather than the current situation. Also, estimates were
calculated based on area of residence at diagnosis. Peo-
ple may have migrated to different areas leading up to
Very Remote  Major City, Inner Regional, 
Outer Regional or Remote 
Most Advantaged 
Moderately Advantaged
to Most Disadvantaged 
0/57 
Pr(H)=0.00 
(0.00,0.00) 
4/95 
Pr(H)=0.24 
(0.16,0.33) 
50/324 
Pr(H)=0.58 
(0.52,0.63) 
Females 
Males 
Remote or 
Very Remote 
Major City, Inner Regional 
or Outer Regional 
Disadvantaged 
Advantaged  
or Middle SES 
0/82 
Pr(H)=0.00 
(0.00,0.00) 
24/124 
Pr(H)=0.44 
(0.36,0.53) 
68/272 
Pr(H)=0.60 
(0.54,0.66) 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
Figure 2 The final classification and regression tree for melanoma.
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Page 6 of 11Outer Regional, Remote or 
Very Remote 
Major City or Inner 
Regional 
Inner Regional  Major City 
Most 
Disadvantaged 
Most Advantaged to 
Moderately Disadvantaged
Moderately Advantaged  
to Most Disadvantaged 
Most 
Advantaged 
2/167 
Pr(H)=0.08 
(0.04,0.12) 
5/52 
Pr(H)=0.33 
(0.20,0.46) 
2/7 
Pr(H)=0.70 
(0.36,1.00) 
1/19 
Pr(H)=0.30 
(0.09,0.50) 
69/233 
Pr(H)=0.67 
(0.61,0.73) 
MC  IR  OR  R  VR 
MA          
ModA                
MSES                
ModD                
MD                
Females 
Figure 3 The final classification and regression tree for breast cancer.
Most 
Disadvantaged 
Most Advantaged 
to  Moderately 
Disadvantaged 
Major City to Remote 
Major City or Inner 
Regional  
Outer Regional 
or Remote 
Most 
Disadvantaged  Non-Indigenous 
Very Remote 
8/288 
Pr(H)=0.22 
(0.17,0.26) 
0/21 
Pr(H)=0.00 
(0.00,0.00) 
12/74 
Pr(H)=0.60 
(0.49,0.71) 
42/59 
Pr(H)=0.94 
(0.88,1.00) 
6/23 
Pr(H)=0.77 
(0.60,0.94) 
Indigenous 
7/13 
Pr(H)=0.89 
(0.72,1.00) 
Most Advantaged 
to  Moderately 
Disadvantaged 
Females 
For non-Indigenous: 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
For Indigenous: 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
Figure 4 The final classification and regression tree for cervical cancer.
Cramb et al. BMC Cancer 2011, 11:311
http://www.biomedcentral.com/1471-2407/11/311
Page 7 of 11their cancer diagnosis, and any carcinogenic exposure or
other area-level influences may have occurred at a dif-
ferent location to where they were diagnosed.
The CART analysis was weighted by the inverse of the
variance, which had the effect of placing greater priority
on correctly identifying SLAs with high SIRs (or sensitiv-
ity), so the specificity (correct identification of SLAs with
non-high SIRs) was found to vary considerably between
cancers and gender. Two cancers with comparatively low
sensitivity and specificity were prostate cancer and male
melanoma. Therefore, results for these models should be
treated with caution.
The ‘high’ SIR values were classified as an arbitrary cut-
off of at least 10% above the Queensland average. This
value was chosen to increase the probability that results
w e r et r u l ya b o v et h eS t a t ea v e r a g ev a l u e s .S i n c ei tw a s
probable that choosing alternate cut-off values would
influence the tree structure, sensitivity analyses (not
shown) were performed under alternate cut-offs (5% and
15% above the Queensland average). Although different
cut-off values often induced some variation in tree struc-
ture, the primary split remained identical for all cancers
except for minor differences in the categories included on
either side of the split for male lung cancer, female breast
cancer, cervical cancer, prostate cancer and male non-
Hodgkin’sl y m p h o m a .
Since the incidence of some cancers such as breast,
melanoma and prostate is strongly influenced by screen-
ing practices, high incidence may result from overdiag-
nosis, where asymptomatic cancers are detected which
would not otherwise have progressed to cause morbidity
and/or death. While in this case a high incidence of can-
cers may not necessarily be an adverse outcome in itself,
the morbidity associated with subsequent treatment is
sometimes considerable [41]. Similarly, low incidence
may not necessarily be beneficial if the cancers which
are diagnosed are detected at a more advanced stage
and therefore have worse prognosis. Consistent with
other Australian Cancer Registries, the QCR does not
routinely collect staging information for all cancers.
Therefore it was not possible to differentiate between
areas at high risk of having advanced cancers diagnosed,
and those at high risk of having sub-clinical cancers
diagnosed.
Alternative methods are available to explore interac-
tions. For instance, increasingly cancers are jointly mod-
elled, either using multivariate structures on the relative
risks, or latent class models [42]. One benefit of these
methods is utilizing strength between the cancers to pro-
duce more efficient estimates [43]. By exploring spatial
variation in common risk factors, latent class models can
provide stronger evidence of any true clustering in the
Remote or Very Remote  Major City, Inner Regional or 
Outer Regional 
Major City 
Moderately Advantaged  
to Most Disadvantaged 
Most 
Advantaged 
Inner or Outer Regional
22/168 
Pr(H)=0.41 
(0.33,0.48) 
1/82 
Pr(H)=0.03 
(0.00,0.07) 
20/84 
Pr(H)=0.63 
(0.53,0.74) 
50/144 
Pr(H)=0.63 
(0.55,0.71) 
Males 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
Figure 5 The final classification and regression tree for prostate cancer.
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Page 8 of 11underlying risk surface [43]. However, under latent class
joint modeling the shared components (risk factors) for
each cancer are pre-specified, whereas the CART analysis
determines which of the risk factors are relevant for that
cancer. The use of different modelling strategies may
identify different features of the data that can lead to bet-
ter understanding of the problem at hand and can thus
lead to more informed inference. For example, in addi-
tion to being a valid approach in its own right, a CART
model may identify useful interactions for inclusion in a
Inner Regional  
to Very Remote  Major City 
2/226 
Pr(H)=0.05 
(0.02,0.08) 
56/252 
Pr(H)=0.69 
(0.63,0.74) 
Females 
Males 
Remote or 
Very Remote 
Major City, Inner Regional 
or Outer Regional 
Outer Regional 
Major City or 
Inner Regional 
0/82 
Pr(H)=0.00 
(0.00,0.00) 
6/85 
Pr(H)=0.32 
(0.22,0.41) 
52/311 
Pr(H)=0.60 
(0.54,0.65) 
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
MC  IR  OR  R  VR 
MA                
ModA                
MSES                
ModD                
MD                
Figure 6 The final classification and regression tree for non-Hodgkin’s lymphoma.
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Page 9 of 11subsequent (univariate or multivariate) regression
analysis.
Conclusions
Identifying which area-level factors are associated with
increased incidence enables targeting of resources as
well as focusing further exploration for the underlying
reasons. This study showed that the accessibility of an
area was the main predictor of high incidence for most
cancers examined. More often it was the more urban
areas which had high cancer incidence, although notable
exceptions were cervical and lung cancers (males). In
addition, many cancers experienced interaction of the
area-level effects, particularly between accessibility and
socioeconomic status. These findings highlight the
importance of conducting further research exploring the
potentially complex reasons underlying these geographi-
cal inequalities.
Appendix
R code used for the CART model:
library(rpart)
#grow the classification tree
fit<- rpart(fail ~ accessibility + socioeconomic + indi-
genous, weight = weight, method="class”,p a r m s=l i s t
(prior = c(.5,.5), split=’information’), data = data, cp =
0.0001)
printcp(fit) # display the results
plotcp(fit) # visualize cross-validation results
summary(fit) # detailed summary of splits
# plot tree
plot(fit, uniform = TRUE, main="Classification Tree”)
text(fit, use.n = TRUE, all = TRUE, cex=.8)
# prune the tree
pfit<- prune(fit, cp = fit$cptable[which.min(fit$cptable
[, “xerror"]), “CP"])
# plot the pruned tree
plot(pfit, uniform = TRUE, main="Pruned Classifica-
tion Tree”)
text(pfit, use.n = TRUE, all = TRUE, cex=.8)
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